Amneal Pharmaceuticals (AMRX) Assets Average (2018 - 2026)

Amneal Pharmaceuticals' Assets Average history runs 9 years deep, the most recent figure standing at $3.6 billion for Q1 2026.

• In Q1 2026, Assets Average rose 5.12% year-over-year to $3.6 billion; the TTM figure through Mar 2026 stood at $3.6 billion (up 5.12% YoY), while the FY2025 annual figure was $3.6 billion, up 2.95% from the prior year.
• Assets Average was $3.6 billion for Q1 2026 at Amneal Pharmaceuticals, down from $3.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.0 billion in Q2 2022 to a low of $3.4 billion in Q2 2025.
• Historically, Assets Average has averaged $3.6 billion across 5 years, with a median of $3.6 billion in 2026.
• The sharpest annual moves came in 2023 and 2026: Assets Average declined 7.6% in 2023, then advanced 5.12% in 2026.
• A 5-year view of Assets Average shows it stood at $3.8 billion in 2022, then slipped by 6.69% to $3.6 billion in 2023, then fell by 2.75% to $3.5 billion in 2024, then rose by 4.53% to $3.6 billion in 2025, then dropped by 0.82% to $3.6 billion in 2026.
• The last three Assets Average figures came in at $3.6 billion (Q1 2026), $3.6 billion (Q4 2025), and $3.5 billion (Q3 2025), per Business Quant data.